LOADING
Comparing NVIDIA Corporation (NVDA) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | TMO |
|---|---|---|
| Price | $199.00 | $492.20 |
| Change Today | -0.52% | +4.87% |
| Market Cap | $4.85T | $172.4B |
| P/E Ratio | 30.7 | 25.5 |
| Forward P/E | 22.8 | 18.6 |
| PEG Ratio | 0.62 | 1.53 |
| EPS | $6.52 | $18.19 |
| Revenue Growth (YoY) | 85.2% | 6.2% |
| Profit Margin | 63.0% | 15.1% |
| Return on Equity | 114.3% | 13.5% |
| Dividend Yield | 0.02% | 0.38% |
| Beta | 2.20 | 0.87 |
| 52-Week High | $236.26 | $642.71 |
| 52-Week Low | $151.29 | $399.99 |
| Volume | 151.8M | 2.1M |
NVIDIA Corporation is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Thermo Fisher Scientific offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.